Unraveling the Path to Market in Canada: Q&A Addressing Seven Common Questions from Manufacturers

Recent Press Releases

• EVERSANA Earns Prestigious Designations from Leading Organizations for Specialty Pharmacy Operations Excellence, Superior Care for Rare Disease Patients
• ConTIPI Medical & EVERSANA Announce U.S. Commercial Launch of Non-Surgical Medical Device ProVate for Women With Pelvic Organ Prolapse
• EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries
• EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model
• EVERSANA Expands Safety Case Management Capabilities with Oracle